Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheet (Parenthetical)

v2.4.0.6
Consolidated Balance Sheet (Parenthetical) (USD $)
In Millions, except Share data, unless otherwise specified
Mar. 31, 2013
Dec. 31, 2012
Assets    
Federal funds sold and securities borrowed or purchased under agreements to resell, measured at fair value $ 94,673 $ 98,670
Trading account assets, pledged as collateral 107,363 115,821
Debt securities:    
Available-for-sale, pledged as collateral 54,457 63,349
Held-to-maturity, at cost, fair value 49,774 50,270
Held-to-maturity Securities Pledged as Collateral 21,491 22,461
Loans and leases, measured at fair value 8,820 9,002
Loans and leases, pledged as collateral 70,982 50,289
Mortgage servicing rights 5,776 5,716
Loans held-for-sale, measured at fair value 13,887 11,659
Other Assets 23,243 26,490
Deposits in U.S. offices:    
Interest-bearing, measured at fair value 2,130 2,262
Federal funds purchased and securities loaned or sold under agreements to repurchase 47,842 42,639
Commercial paper and other short-term borrowings, measured at fair value 3,168 4,074
Accrued expenses and other liabilities, measured at fair value 14,285 16,594
Accrued expenses and other liabilities, reserve for unfunded lending commitments 486 513
Long-term debt, measured at fair value 52,361 49,161
Shareholders' equity    
Preferred stock, par value $ 0.01 $ 0.01
Preferred stock, authorized shares 100,000,000 100,000,000
Preferred stock, issued shares 3,685,410 3,685,410
Preferred stock, outstanding shares 3,685,410 3,685,410
Common stock, par value $ 0.01 $ 0.01
Common stock, authorized shares 12,800,000,000 12,800,000,000
Common stock, issued shares 10,822,379,936 10,778,263,628
Common stock, outstanding shares 10,822,379,936 10,778,263,628
Consolidated VIEs [Member] | Short-term Debt [Member]
   
Shareholders' equity    
Non-recourse debt 784 872
Consolidated VIEs [Member] | Long-term debt
   
Shareholders' equity    
Non-recourse debt 26,647 29,476
Consolidated VIEs [Member] | Other Liabilities
   
Shareholders' equity    
Non-recourse debt $ 140 $ 149